International Journal of Hematology
This official journal of the Japanese Society of Hematology covers all aspects of the field of hematology, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy.
The International Journal of Hematology (IJH) has a long history of publishing leading research in the field. It features articles that contribute to progress in research not only in basic hematology but also in clinical hematology. The expanded Progress in Hematology section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. In addition, the journal includes reports on results of clinical trials, which help foster communication among researchers in the growing field of modern hematology.
The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.
Color figures are free.
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system
Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation
- Journal Title
- International Journal of Hematology
- Volume 73 / 2001 - Volume 109 / 2019
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.